In order to explore the unique pathways involved in p190-CML leukemogenesis, we integrated exome sequencing, RNA sequencing and phosphorylation profiling to characterize a small cohort of p190-CML patients. The gene discussed is CNTNAP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.